Twitter Facebook LinkedIn YouTube

Videos Tagged: pharmaceutical

Voyageur Pharmaceuticals receives additional licenses from Health Canada for its MultiX barium sulfate powder product for use in single contrast radiographic examinations
Voyageur Pharmaceuticals receives additional licenses from Health Canada for its MultiX barium sulfate powder product for use in single contrast radiographic examinations
ZEN Graphene has been advised by Trebor Rx Corp. that their surgical masks with ZEN's biocidal coating passed testing requirements as a level 2 medical device
ZEN Graphene has been advised by Trebor Rx Corp. that their surgical masks with ZEN's biocidal coating passed testing requirements as a level 2 medical device
New Listing: Tryp Therapeutics Inc. (CSE:TRYP)
New Listing: Tryp Therapeutics Inc. (CSE:TRYP)
Voyageur Pharmaceuticals (TSXV:VM) Announced two non-brokered Private Placements
Voyageur Pharmaceuticals (TSXV:VM) Announced two non-brokered Private Placements
Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization
Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization
FSD Pharma receives approval for application to list on NASDAQ Capital Market
FSD Pharma receives approval for application to list on NASDAQ Capital Market
New Listing: InnoCan Pharma Corporation (CSE:INNO)
New Listing: InnoCan Pharma Corporation (CSE:INNO)
FSD Pharma signs LOI to establish JV with World Class Extractions for extraction facility in Ontario
FSD Pharma signs LOI to establish JV with World Class Extractions for extraction facility in Ontario
New Listing: Appili Therapeutics (TSXV:APLI)
New Listing: Appili Therapeutics (TSXV:APLI)
New Listing: GreenStar Biosciences (CSE:GSTR)
New Listing: GreenStar Biosciences (CSE:GSTR)
Willow Biosciences and Noramco announce joint development of biosynthesis platform for cannabidiol
Willow Biosciences and Noramco announce joint development of biosynthesis platform for cannabidiol
Benchmark Botanics signs letter of intent with China-based Zejiang Yatai Pharmaceutical to advance CBD products
Benchmark Botanics signs letter of intent with China-based Zejiang Yatai Pharmaceutical to advance CBD products
New Listing: Willow Biosciences (CSE:WLLW)
New Listing: Willow Biosciences (CSE:WLLW)
New Listing: Vireo Health International (CSE:VREO)
New Listing: Vireo Health International (CSE:VREO)
Valeo Pharma Inc. (CSE:VPH) New Listing
Valeo Pharma Inc. (CSE:VPH) New Listing
FSD Pharma signs non-binding LOI with Solarvest BioEnergy to develop and test pharma-grade cannabinoids from algae
FSD Pharma signs non-binding LOI with Solarvest BioEnergy to develop and test pharma-grade cannabinoids from algae
Organic Flower Investments Group (CSE:SOW) New Listing
Organic Flower Investments Group (CSE:SOW) New Listing
Medexus Pharmaceuticals (TSXV:MDP) New Listing
Medexus Pharmaceuticals (TSXV:MDP) New Listing
FSD Pharma Inc. has appointed Rupert Haynes as Chief Executive Officer
FSD Pharma Inc. has appointed Rupert Haynes as Chief Executive Officer
FSD Pharma, a licensed cannabis producer, adds high level government relations executive, David Urban to Board of Directors
FSD Pharma, a licensed cannabis producer, adds high level government relations executive, David Urban to Board of Directors
FSD Pharma signs binding letter of intent to acquire NASDAQ-listed Therapix Biosciences, a developer of cannabinoid-based treatments
FSD Pharma signs binding letter of intent to acquire NASDAQ-listed Therapix Biosciences, a developer of cannabinoid-based treatments
North Bud Farms (CSE:NBUD) New Listing
North Bud Farms (CSE:NBUD) New Listing
Callitas Health Inc (CSE:LILY) has signed a consulting agreement with BFS Innovations and Pure Leaf Group
Callitas Health Inc (CSE:LILY) has signed a consulting agreement with BFS Innovations and Pure Leaf Group
Graphene 3D Lab (TSXV:GGG) Entered into a Technology Transfer Agreement with “Industrial Partner”
Graphene 3D Lab (TSXV:GGG) Entered into a Technology Transfer Agreement with “Industrial Partner”
HLS Therapeutics Inc. (TSXV:HLS) New Listing
HLS Therapeutics Inc. (TSXV:HLS) New Listing
Naturally Splendid announced the sale of its 51% majority interest in POS BPC Mfg. Corp.
Naturally Splendid announced the sale of its 51% majority interest in POS BPC Mfg. Corp.
Naturally Splendid (TSXV: NSP) will be applying to become a Licensed Dealer of cannabis extracts under Canadian regulations
Naturally Splendid (TSXV: NSP) will be applying to become a Licensed Dealer of cannabis extracts under Canadian regulations
NanoSphere Health Sciences Inc. (CSE:NSHS) New Listing
NanoSphere Health Sciences Inc. (CSE:NSHS) New Listing
Eviana Health Corporation (CSE:EHC) New Listing
Eviana Health Corporation (CSE:EHC) New Listing
CannTrust Holdings (CSE: TRST) New Listing
CannTrust Holdings (CSE: TRST) New Listing